Vertical Research Downgrades C.H. Robinson Worldwide to Sell
Vertical Research analyst Jeffrey Kauffman downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Hold to Sell.
Wedbush Downgrades FuboTV to Neutral, Raises Price Target to $6
Wedbush analyst Michael Pachter downgrades FuboTV (NYSE:FUBO) from Outperform to Neutral and raises the price target from $5 to $6.
Citigroup Downgrades HUYA to Neutral, Lowers Price Target to $4
Citigroup analyst Brian Gong downgrades HUYA (NYSE:HUYA) from Buy to Neutral and lowers the price target from $6 to $4.
Guggenheim Downgrades Teladoc Health to Sell, Announces $25 Price Target
Guggenheim analyst Sandy Draper downgrades Teladoc Health (NYSE:TDOC) from Neutral to Sell and announces $25 price target.
Deutsche Bank Downgrades Take-Two Interactive to Hold, Lowers Price Target to $160
Deutsche Bank analyst Bryan Kraft downgrades Take-Two Interactive (NASDAQ:TTWO) from Buy to Hold and lowers the price target from $200 to $160.
TPI Composites Faces Downgrade By This Analyst As New Incentive Will Take Time For Profit Contribution
Raymond James analyst Pavel Molchanov downgraded TPI Composites Inc (NASDAQ:TPIC) to Outperform from Strong Buy and raised the price target to $28 (an…
Clean Energy Fuels Downgraded At Raymond James, In Response To Inflation Recovery Act
Raymond James analyst Pavel Molchanov downgraded Clean Energy Fuels Corp (NASDAQ:CLNE) to Market Perform, from Outperform, without a price target. The analyst…
Alembic Global Downgrades Albany Intl to Neutral
Alembic Global analyst Peter Skibitski downgrades Albany Intl (NYSE:AIN) from Overweight to Neutral.
Maxim Group Downgrades Aridis Pharmaceuticals to Hold
Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.
Why This Bed Bath & Beyond Analyst Is Turning Bearish: ‘Fundamental Issues’
Shares of Bed Bath & Beyond Inc (NASDAQ: BBBY) have gained more than 35% over the last three months after gaining the attention of retail tra